TCRB1 & TCRB2 for IHC
Making T-Cell Clonality Visible
TCRB1 & TCRB2 immunohistochemistry introduces a tissue-based approach to T-cell clonality assessment, bringing a concept analogous to B-cell light-chain restriction into T-cell lymphoma diagnostics.
The Diagnostic Challenge
T-cell lymphomas, particularly cutaneous T-cell lymphomas (CTCL) such as mycosis fungoides (MF), are often difficult to distinguish from benign inflammatory T-cell infiltrates. Early disease may mimic common dermatoses for years, resulting in:
- in delayed diagnosis
- repeated biopsies
- ineffective treatment strategies.
T-cell receptor (TCR) clonality testing relies mainly on multiplex PCR-based methods, which are complex, costly, and require specialized expertise. The new TCRB1 & TCRB2 IHC markers are about to change this……………………..
The Principle: Detecting T-Cell Monotypia
T cells express one of two highly similar T-cell receptor beta constant regions:
• TCRB1 (TRBC1, TCRbeta1)
• TCRB2 (TRBC2, TCRbeta2)
In healthy polyclonal T-cell populations, TCRB1 and TCRB2 are expressed at an approximately 1:1 ratio. This balanced distribution provides a robust biological baseline, making deviations from normal expression readily detectable. In contrast, clonal T-cell populations exhibit TCRB1-or TCRB2-restriction, enabling direct immunohistochemical visualization of T-cell monotypia in routine FFPE tissue sections. This principle is comparable to kappa/lambda-restriction analysis in B-cell neoplasms.
Clinical & Healthcare Impact
TCRB1/TCRB2 immunostaining provides a rapid, tissue-based approach to T-cell clonality assessment, enabling:
• Accurate detection of clonal T-cell populations
• Diagnosis of mycosis fungoides and other cutaneous T-cell lymphomas
• Reliable differentiation of reactive and neoplastic T-cell infiltrates
• Earlier diagnosis to support timely treatment decisions
• Cost-effective implementation with reduced reliance on molecular clonality testing
Literature
[1] Soilleux EJ, Rodgers DT, Situ JJ et al. Diagnostics (Basel). 2024 Nov 6;14(22):2479.
[2] Kaistha A, Situ JJ, Evans S et al. J Clin Pathol. 2026 Jun 18;79(7):486-493.
Status: Available Now (IVD in progress)
Format: RTU
TCRB1: CSP/17/0/P-TO11-xxx
TCRB2: CSP/17/0/P-TO12-xxx
